Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OTC Deficiency”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Large-scale testing (Phase 3)Study completedNCT06431113
What this trial is testing

Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma

Who this might be right for
GlaucomaNeuroprotection
Fondazione IRCCS Policlinico San Matteo di Pavia 40
Testing effectiveness (Phase 2)Study completedNCT02991144
What this trial is testing

Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset Ornithine Transcarbamylase (OTC) Deficiency

Who this might be right for
Ornithine Transcarbamylase (OTC) Deficiency
Ultragenyx Pharmaceutical Inc 16
Not applicableStudy completedNCT06845397
What this trial is testing

Chuvashia Inappropriate Prescribing Study

Who this might be right for
Multimorbidity, Cardiovascular Diseases
National Medical Research Center for Therapy and Preventive Medicine 300
Early research (Phase 1)Study completedNCT04442347
What this trial is testing

Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency

Who this might be right for
Ornithine Transcarbamylase Deficiency
Arcturus Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Looking for participantsNCT06488313
What this trial is testing

Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

Who this might be right for
OTC DeficiencyOrnithine Transcarbamylase DeficiencyOTCD
Arcturus Therapeutics, Inc. 9
Not applicableStudy completedNCT01569568
What this trial is testing

Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI

Who this might be right for
Ornithine Transcarbamylase Deficiency
Andrea Gropman 49
Testing effectiveness (Phase 2)Ended earlyNCT05526066
What this trial is testing

Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810

Who this might be right for
Ornithine Transcarbamylase DeficiencyOTC DeficiencyOTCD
Arcturus Therapeutics, Inc. 8
Not applicableLooking for participantsNCT02132741
What this trial is testing

Optical Coherence Tomography And NEphropathy: The OCTANE Study

Who this might be right for
HealthHypertensionChronic Kidney Disease
University of Edinburgh 150
Not applicableLooking for participantsNCT06805695
What this trial is testing

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

Who this might be right for
Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn
iECURE, Inc. 13
Not applicableStudy completedNCT01080859
What this trial is testing

Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography

Who this might be right for
Acute Coronary Syndrome
The Hospital District of Satakunta 40
Testing effectiveness (Phase 2)Study completedNCT01599286
What this trial is testing

Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia

Who this might be right for
Propionic Acidemia, Type I and/or Type IIMethylmalonic AcidemiaCarbamoyl-Phosphate Synthase I Deficiency Disease+1 more
Mendel Tuchman 35
Not applicableNot Yet RecruitingNCT07241845
What this trial is testing

Epiretinal Membrane in Patients With DR.

Who this might be right for
Epiretinal Membrane
Assiut University 225
Testing effectiveness (Phase 2)WithdrawnNCT01791192
What this trial is testing

Study of FTY720 in Patients With Uveitis

Who this might be right for
Acute Noninfectious Posterior, Intermediate, or Pan Uveitis
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT05299710
What this trial is testing

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

Who this might be right for
Cancers
Erin Rowell 250
Post-approval studies (Phase 4)Study completedNCT01742507
What this trial is testing

A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study

Who this might be right for
Coronary Artery Disease
The University of Hong Kong 60
Early research (Phase 1)Not Yet RecruitingNCT06735638
What this trial is testing

Outside the Cage (OTC) Robotic Esophagectomy

Who this might be right for
Esophageal Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 31
Not applicableUnknownNCT05301218
What this trial is testing

CAlcified Lesion Intervention Planning Steered by OCT.

Who this might be right for
Coronary Artery CalcificationAngioplasty
Institut Mutualiste Montsouris 140
Early research (Phase 1)Study completedNCT04416126
What this trial is testing

Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects

Who this might be right for
Ornithine Transcarbamylase Deficiency
Arcturus Therapeutics, Inc. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05345171
What this trial is testing

Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

Who this might be right for
OTC Deficiency
Ultragenyx Pharmaceutical Inc 37
Not applicableStudy completedNCT04444037
What this trial is testing

Impact of OCT Imaging on Decision Making During PCI in ACS Patients

Who this might be right for
Acute Coronary Syndrome
Assiut University 390
Next Page